S3722 HCPCS code: Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
S3722 is the HCPCS Level II code for dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.
Code details
| Field | Value |
|---|---|
| Section | S codes — Temporary national codes (non-Medicare) |
| Coverage code | I — Not payable by Medicare |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2012-01-01 |
| Last action effective | 2012-01-01 |
What changed for S3722
- 2012-01-01: S3722 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code S3722?
S3722 is the HCPCS Level II code for dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil. Short descriptor: "Dose optimization auc - 5fu".
Does Medicare cover S3722?
Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.
Related S37 codes
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under S3722
- Watch S3722 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for S3722
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.